Valizadeh, P., Mozafari, N., Ashrafi, H., Heidari, R., Azarpira, N., & Azadi, A. (2025). Saccharomyces cerevisiae-derived vesicles loaded with dextromethorphan as a candidate for the management of neuroinflammation related to Alzheimer's disease. Pharmaceutical Development & Technology, 30(3), 259. https://doi.org/10.1080/10837450.2025.2470351
Chicago Style (17th ed.) CitationValizadeh, Parastoo, Negin Mozafari, Hajar Ashrafi, Reza Heidari, Negar Azarpira, and Amir Azadi. "Saccharomyces Cerevisiae-derived Vesicles Loaded with Dextromethorphan as a Candidate for the Management of Neuroinflammation Related to Alzheimer's Disease." Pharmaceutical Development & Technology 30, no. 3 (2025): 259. https://doi.org/10.1080/10837450.2025.2470351.
MLA (9th ed.) CitationValizadeh, Parastoo, et al. "Saccharomyces Cerevisiae-derived Vesicles Loaded with Dextromethorphan as a Candidate for the Management of Neuroinflammation Related to Alzheimer's Disease." Pharmaceutical Development & Technology, vol. 30, no. 3, 2025, p. 259, https://doi.org/10.1080/10837450.2025.2470351.